Daiwa Securities Group Inc. - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 200 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5
-16.7%
2040.0%0.00%
Q2 2023$6
+20.0%
2040.0%0.00%
Q1 2023$5
-16.7%
2040.0%0.00%
Q4 2022$6
-99.9%
2040.0%0.00%
Q3 2022$6,000
+20.0%
2040.0%0.00%
Q2 2022$5,0000.0%204
+29.1%
0.00%
Q1 2022$5,0000.0%1580.0%0.00%
Q4 2021$5,000
-44.4%
158
-21.8%
0.00%
Q3 2021$9,000
+28.6%
202
+65.6%
0.00%
Q2 2021$7,0000.0%122
-11.6%
0.00%
Q1 2021$7,000
+16.7%
138
+6.2%
0.00%
Q4 2020$6,000
-57.1%
130
-66.3%
0.00%
Q3 2020$14,0000.0%3860.0%0.00%
Q2 2020$14,0000.0%3860.0%0.00%
Q1 2020$14,000
-22.2%
3860.0%0.00%
Q4 2019$18,000
+50.0%
386
+4.0%
0.00%
Q3 2019$12,000
-36.8%
3710.0%0.00%
Q2 2019$19,000
-24.0%
3710.0%0.00%
Q1 2019$25,000
+78.6%
371
+18.2%
0.00%
Q4 2018$14,000
-41.7%
3140.0%0.00%
Q3 2018$24,000
-7.7%
3140.0%0.00%
Q2 2018$26,0000.0%3140.0%0.00%
Q1 2018$26,0003140.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,661,605$61,137,0671.46%
Bellevue Group AG 4,013,500$92,190,0951.34%
Eagle Health Investments LP 267,630$6,147,4611.20%
ARMISTICE CAPITAL, LLC 3,460,000$79,476,2001.14%
Integral Health Asset Management, LLC 213,000$4,892,6100.99%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$10,428,3800.44%
ArrowMark Colorado Holdings LLC 1,557,705$35,780,4840.41%
FARALLON CAPITAL MANAGEMENT LLC 2,092,829$48,072,2820.27%
Virtus ETF Advisers LLC 9,932$228,1380.13%
JACOBS LEVY EQUITY MANAGEMENT, INC 614,533$14,115,8230.09%
View complete list of AGIOS PHARMACEUTICALS INC shareholders